Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pristinamycin in the Treatment of MSSA Bone and Joint Infection

NCT03177343 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT03177343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03177343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pristinamycin in the Treatment of MSSA Bone and Joint Infection
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
August 31, 2015
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone and joint infection, methicillin susceptible staphylococcus aureus (mssa) infection